NCT05257044View on ClinicalTrials.gov

Acute Effects of Cannabigerol

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 24, 2022

Primary Completion Date

November 28, 2023

Study Completion Date

November 28, 2023

Conditions
Focus: To Examine Acute Effects of CBG on Anxiety, Stress, and Cognition
Interventions
DRUG

Cannabigerol

Participants will ingest CBG and placebo in a double-blind randomized cross-over design

OTHER

Placebo

Placebo

Trial Locations (1)

99164

Washington State University, Pullman

All Listed Sponsors
lead

Washington State University

OTHER